0001104659-24-025684.txt : 20240220
0001104659-24-025684.hdr.sgml : 20240220
20240220195218
ACCESSION NUMBER: 0001104659-24-025684
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240220
FILED AS OF DATE: 20240220
DATE AS OF CHANGE: 20240220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCPEAK MERRILL A
CENTRAL INDEX KEY: 0001210317
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36860
FILM NUMBER: 24655933
MAIL ADDRESS:
STREET 1: PO BOX 500 (M/S 55-985)
STREET 2: 14200 SW KARL BRAUN DRIVE
CITY: BEAVERTON
STATE: OR
ZIP: 97077-0001
FORMER NAME:
FORMER CONFORMED NAME: MCPEAK MERRILL A/
DATE OF NAME CHANGE: 20021214
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IOVANCE BIOTHERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001425205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 753254381
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: 4TH FLOOR
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 6502607120
MAIL ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: 4TH FLOOR
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
FORMER COMPANY:
FORMER CONFORMED NAME: Lion Biotechnologies, Inc.
DATE OF NAME CHANGE: 20131015
FORMER COMPANY:
FORMER CONFORMED NAME: Genesis Biopharma, Inc
DATE OF NAME CHANGE: 20100319
FORMER COMPANY:
FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP
DATE OF NAME CHANGE: 20080128
4
1
tm246751-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-20
0
0001425205
IOVANCE BIOTHERAPEUTICS, INC.
IOVA
0001210317
MCPEAK MERRILL A
C/O IOVANCE BIOTHERAPEUTICS, INC.
825 INDUSTRIAL ROAD, 4TH FLOOR
SAN CARLOS
CA
94070
1
0
0
0
0
Common Stock
2024-02-20
4
P
0
250000
9.15
A
320150
D
Common Stock
248633
I
By Trust
These shares are held by a family trust for which the reporting person is a trustee.
Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024.
Such number does not include 103,159 deferred restricted stock units, which are vested but not yet issued.
Consists of 30,150 shares held in Keogh retirement account plus 40,000 shares as a result of exercised stock options plus 250,000 shares acquired in this offering.
/s/ Merrill A. McPeak
2024-02-20